dalteparin has been researched along with urea in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daelemans, R; Hosten, S; Lens, S; Lins, RL; Mattheeussen, J; Vanuytsel, JL; Zachée, P | 1 |
Deepa, PR; Varalakshmi, P | 1 |
Avni, B; Efrati, S; Golik, A; Koren-Michowitz, M; Michowitz, Y; Moravski, G | 1 |
Bamichas, GI; Fragia, TK; Fragidis, SK; Georgoulis, IE; Gionanlis, LC; Natse, TA; Sombolos, KI; Veneti, PE | 1 |
Devreese, K; Dhondt, A; Eloot, S; Glorieux, G; Pauwels, R; Vanholder, R | 1 |
Crijns, HJ; De Boer, HC; De Jong, AM; Kamphuisen, PW; Kuiper, M; Lau, DH; Linz, D; Lumeij, S; Maass, AH; Rienstra, M; Schotten, U; Spronk, HM; Ten Cate, H; Van Gelder, IC; van Hunnik, A; van Zonneveld, AJ; Verheule, S; Zeemering, S | 1 |
3 trial(s) available for dalteparin and urea
Article | Year |
---|---|
Comparison of different routes of administration of nadroparin in hemodialysis.
Topics: Adult; Aged; Anticoagulants; Creatinine; Cross-Over Studies; Factor Xa; Female; Hemoglobins; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Nadroparin; Renal Dialysis; Urea | 1999 |
Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
Topics: Aldosterone; Anticoagulants; Creatinine; Enoxaparin; Female; Humans; Hydrogen-Ion Concentration; Hyperkalemia; Male; Middle Aged; Platelet Count; Prospective Studies; Sodium; Urea | 2004 |
Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial.
Topics: Anticoagulants; beta 2-Microglobulin; Blood Coagulation; Cross-Over Studies; Factor Xa Inhibitors; Female; Hemodiafiltration; Heparin, Low-Molecular-Weight; Humans; Kidney Failure, Chronic; Leukocyte Count; Male; Tinzaparin; Treatment Outcome; Urea | 2015 |
3 other study(ies) available for dalteparin and urea
Article | Year |
---|---|
Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis.
Topics: Albinism; Alkaline Phosphatase; Animals; Arteriosclerosis; Cholesterol; Creatine; Creatine Kinase; Diet, Atherogenic; Heart; Heparin, Low-Molecular-Weight; Kidney; L-Lactate Dehydrogenase; Liver; Male; Rats; Rats, Wistar; Serum Albumin; Transaminases; Urea; Uric Acid | 2004 |
The anticoagulant activity of enoxaparin sodium during on-line hemodiafiltration and conventional hemodialysis.
Topics: Adult; Aged; Anticoagulants; Enoxaparin; Factor Xa Inhibitors; Female; Hemodiafiltration; Humans; Male; Middle Aged; Partial Thromboplastin Time; Renal Dialysis; Urea | 2009 |
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
Topics: Analysis of Variance; Animals; Antithrombins; Atrial Fibrillation; Cell Proliferation; Dabigatran; Female; Fibrinolytic Agents; Fibroblasts; Fibrosis; Goats; Heart Atria; Indazoles; Mice, Transgenic; Nadroparin; Peptide Hydrolases; Pyrroles; Quinazolines; Rats; Receptors, Thrombin; Thrombin; Thrombophilia; Urea | 2017 |